EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes

Thomas R Bowhay iD, Tiffany Tsang, Jeremy C Z Wei, Wafa Edwik, Avi Fridman, Julia Hubber, Jae Y Jo, Nicole Mckay, Catherine O'Brien, Joe Osmond-Wallam, James Smythe, John A Crump und 1 weitere

Internal Medicine Journal · 2024-02 · 54 (2) · 320-327

DOI: 10.1111/imj.16173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 18.07.2023. Verfasst von Thomas R Bowhay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dunedin Public Hospital, Te Whatu Ora (Health New Zealand) Southern, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Cellulitis, Anti-Infective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Francis G. Cotter Scholarship for Research in Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cellulitis is a common acute skin and soft tissue infection that causes substantial morbidity and healthcare costs.

Aims

To audit the impact on cellulitis management, regimen tolerability and outcomes of switching from outpatient parenteral antimicrobial therapy (OPAT) using intravenous (i.v.) cefazolin once daily plus probenecid to oral beta‐lactam therapy (OBLT) using oral flucloxacillin plus probenecid.

Methods

We undertook a retrospective audit on cellulitis management, regimen tolerability and outcomes at the Dunedin Public Hospital Emergency Department (ED) before and after a change of the local outpatient cellulitis treatment pathway from OPAT using i.v. cefazolin once daily plus probenecid to OBLT using oral flucloxacillin plus probenecid.

Results

OPAT was used in 97/123 (78.9%) patients with cellulitis before compared to 1/70 (1.4%) after the pathway change (odds ratio (OR), 0.04, P < 0.01). OBLT was used in 26/123 (21.1%) patients with cellulitis before and 69/70 (98.6%) after (OR, 218.8, P < 0.01). Antimicrobial change due to intolerance occurred in 4/123 (3.2%) patients with cellulitis before and 4/70 (5.7%) after (OR, 1.8, P , not significant (NS)) the pathway change. Inpatient admission within 28 days occurred in 15/123 (12.2%) cellulitis patients before and 9/70 (12.9%) after (OR, 1.1, P , NS) the pathway change.

Conclusions

Implementation of a change in outpatient cellulitis treatment pathway resulted in a significant change in prescribing practice. Our findings suggest that OBLT was both tolerable and had similar outcomes to OPAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CellulitisAnti-Infective AgentsHumansAnti-Bacterial AgentsCefazolinFloxacillinProbenecidOutpatientsRetrospective StudiesAmbulatory Care

Stichwörter der Autor:innen

antibioticantibiotic guidelinesantimicrobial stewardshipcellulitisoutpatient

Substanzen

Anti-Bacterial AgentsCefazolinFloxacillinProbenecidAnti-Infective Agents

Autor:innen und Institutionen

  • Dunedin Public Hospital, Te Whatu Ora (Health New Zealand) Southern, Dunedin, New Zealand.
  • Centre for International Health, University of Otago, Dunedin, New Zealand.
  • Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Thomas R Bowhay

Förderung

  • Francis G. Cotter Scholarship for Research in Medicine

Zitieren

APA

Bowhay, T. R., Tsang, T., Wei, J. C. Z., Edwik, W., Fridman, A., Hubber, J., Jo, J. Y., Mckay, N., O'Brien, C., Osmond-Wallam, J., Smythe, J., Crump, J. A., & Arnold, B. (2024). Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes. Internal Medicine Journal, 54(2), 320-327. https://doi.org/10.1111/imj.16173

Vancouver

Bowhay TR, Tsang T, Wei JCZ, Edwik W, Fridman A, Hubber J, et al. Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes. Internal Medicine Journal. 2024;54(2):320-327. doi:10.1111/imj.16173

BibTeX
@article{Bowhay2024,
  author = {Bowhay, Thomas R and Tsang, Tiffany and Wei, Jeremy C Z and Edwik, Wafa and Fridman, Avi and Hubber, Julia and Jo, Jae Y and Mckay, Nicole and O'Brien, Catherine and Osmond-Wallam, Joe and Smythe, James and Crump, John A and Arnold, Brendan},
  title = {Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes},
  journal = {Internal Medicine Journal},
  year = {2024},
  volume = {54},
  number = {2},
  pages = {320--327},
  doi = {10.1111/imj.16173}
}
Kostenlos starten →